| A Randomized, Double Blinded, Comparative Observational Interventional Study to Assess The Safety And Immunogenicity Of Hepatitis B Vaccine In Newborns / Adolescents And Adults Six Months Post Vaccination |
Ongoing |
EUVAX B VACCINE |
4 |
HBV-001 |
King Fahad Medical City (Riyadh),General Medical Polyclinic (Jeddah) ,Dafa Special Polyclinic |
| Impact of using Zinc Oxide versus Moist Exposed Wound Ointment (MEBO) in treatment of second stage pressure ulcer: A randomized control clinical trial |
|
|
3 |
|
|
| A Proof of Concept, Phase IIa, Open Label Study to Evaluate the Safety and Efficacy of Subcutaneous Implants of Afamelanotide in Patients with Xeroderma Pigmentosum (XP) |
Terminated |
Afamelanotide |
2a |
CUV156 |
King Faisal Specialist Hospital and Research Center (Riyadh) |
| A randomized, double-blind, double-dummy, parallel-group study, comparing the efficacy and safety of remibrutinib versus teriflunomide in participants with relapsing multiple sclerosis, followed by extended treatment with open-label remibrutinib |
|
|
3 |
|
|
| An Open-label Extension Trial to Evaluate the Long-term Safety of KVD900, an Oral Plasma Kallikrein Inhibitor, for On-demand Treatment of Angioedema Attacks in Adolescent and Adult Patients with Hereditary Angioedema Type I or II |
|
|
3 |
|
|
| A prospective observational international study of cabozantinib tablets in combination with nivolumab as first-line treatment of advanced renal cell carcinoma in adults |
|
|
4 |
|
|
| A Phase 3, Randomized, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Guselkumab in Participants with Fistulizing, Perianal Crohn’s Disease |
|
|
3 |
|
|
| A Randomized, Double-blind, Multicenter Study to Determine the Effect of Triheptanoin Compared with Even-chain, Medium-chain Triglycerides (MCT) on Major Clinical Events (MCEs) in Pediatric Patients with Long-chain Fatty Acid Oxidation Disorders (LC-FAOD) |
|
|
3 |
|
|
| A non-interventional, multinational,observational study with isatuximabin patients with relapsed and/orrefractory multiple myeloma (RRMM) |
|
|
4 |
|
|
| International collaborative treatment protocol for infants under one year with KMT2Arearranged acute lymphoblastic leukemia or mixed phenotype acute leukemia (Interfant-21) |
Ongoing |
BLINATUMOMAB |
3 |
SCT22R/016/12 |
King Abdulaziz Medical City NG (Riyadh),King Abdulaziz Medical City NG (Jeddah) |
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.